Middle East Pharmaceutical Industries Company (TADAWUL: 4016)

Middle East Pharmaceutical Industries Company Statistics

Total Valuation

Middle East Pharmaceutical Industries Company has a market cap or net worth of SAR 2.69 billion. The enterprise value is 2.70 billion.

Market Cap	2.69B
Enterprise Value	2.70B

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	Sep 2, 2024

Share Statistics

Middle East Pharmaceutical Industries Company has 20.00 million shares outstanding.

Shares Outstanding	20.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.20%
Owned by Institutions (%)	0.10%
Float	6.00M

Valuation Ratios

The trailing PE ratio is 33.88 and the forward PE ratio is 28.64.

PE Ratio	33.88
Forward PE	28.64
PS Ratio	7.34
PB Ratio	7.98
P/FCF Ratio	32.36
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.27, with an EV/FCF ratio of 32.47.

EV / Earnings	33.99
EV / Sales	7.36
EV / EBITDA	27.27
EV / EBIT	29.67
EV / FCF	32.47

Financial Position

The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.09.

Current Ratio	2.74
Quick Ratio	1.69
Debt / Equity	0.09
Debt / EBITDA	0.30
Debt / FCF	0.36
Interest Coverage	16.96

Financial Efficiency

Return on equity (ROE) is 25.85% and return on invested capital (ROIC) is 15.85%.

Return on Equity (ROE)	25.85%
Return on Assets (ROA)	12.76%
Return on Capital (ROIC)	15.85%
Revenue Per Employee	675,639
Profits Per Employee	146,324
Employee Count	543
Asset Turnover	0.82
Inventory Turnover	1.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	131.60
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.64
Average Volume (20 Days)	168,834

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Middle East Pharmaceutical Industries Company had revenue of SAR 366.87 million and earned 79.45 million in profits. Earnings per share was 3.97.

Revenue	366.87M
Gross Profit	231.20M
Operating Income	91.03M
Pretax Income	85.32M
Net Income	79.45M
EBITDA	99.04M
EBIT	91.03M
Earnings Per Share (EPS)	3.97

Balance Sheet

The company has 21.63 million in cash and 30.13 million in debt, giving a net cash position of -8.50 million or -0.42 per share.

Cash & Cash Equivalents	21.63M
Total Debt	30.13M
Net Cash	-8.50M
Net Cash Per Share	-0.42
Equity (Book Value)	337.15M
Book Value Per Share	16.86
Working Capital	187.40M

Cash Flow

In the last 12 months, operating cash flow was 104.43 million and capital expenditures -21.25 million, giving a free cash flow of 83.18 million.

Operating Cash Flow	104.43M
Capital Expenditures	-21.25M
Free Cash Flow	83.18M
FCF Per Share	4.16

Margins

Gross margin is 63.02%, with operating and profit margins of 24.81% and 21.66%.

Gross Margin	63.02%
Operating Margin	24.81%
Pretax Margin	23.25%
Profit Margin	21.66%
EBITDA Margin	27.00%
EBIT Margin	24.81%
FCF Margin	22.67%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 1.11%.

Dividend Per Share	1.50
Dividend Yield	1.11%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	22.65%
Buyback Yield	n/a
Shareholder Yield	1.11%
Earnings Yield	2.95%
FCF Yield	3.09%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Middle East Pharmaceutical Industries Company has an Altman Z-Score of 16.33.

Altman Z-Score	16.33
Piotroski F-Score	n/a